|
Volumn 27, Issue SUPPL. 2, 2003, Pages
|
Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
ALPHA GLUCOSIDASE INHIBITOR;
ANTIOBESITY AGENT;
BIGUANIDE DERIVATIVE;
DACLIZUMAB;
GLIBENCLAMIDE;
GLICLAZIDE;
GLIMEPIRIDE;
GLUCONORM;
HUMAN INSULIN;
HUMULIN L;
HUMULIN U;
IMMUNOSUPPRESSIVE AGENT;
INFLUENZA VACCINE;
INSULIN;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN LISPRO;
INSULIN SENSITIZING AGENT;
ISOPHANE INSULIN;
METFORMIN;
METFORMIN PLUS ROSIGLITAZONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NATEGLINIDE;
ORAL ANTIDIABETIC AGENT;
PIOGLITAZONE;
PNEUMOCOCCUS VACCINE;
PRANDASE;
REPAGLINIDE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
TACROLIMUS;
TETRAHYDROLIPSTATIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ADOLESCENT;
ADULT;
AGING;
ANXIETY;
BEHAVIOR THERAPY;
CANADA;
CHILD;
CLINICAL PRACTICE;
COGNITIVE THERAPY;
COPING BEHAVIOR;
DEPRESSION;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
DISEASE CLASSIFICATION;
DRUG CONTRAINDICATION;
DRUG INDICATION;
DYSLIPIDEMIA;
EATING DISORDER;
EDEMA;
EXERCISE;
FAMILY HISTORY;
FAMILY THERAPY;
FEMALE;
FLUID RETENTION;
GASTROINTESTINAL TOXICITY;
GLUCOSE BLOOD LEVEL;
GRAFT REJECTION;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
IMPAIRED GLUCOSE TOLERANCE;
INFLUENZA;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
MALE;
METABOLIC SYNDROME X;
NEPHROTOXICITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NUTRITION;
OBESITY;
ORAL GLUCOSE TOLERANCE TEST;
PANCREAS ISLET TRANSPLANTATION;
PATIENT EDUCATION;
PATIENT MONITORING;
PHYSICAL ACTIVITY;
PRACTICE GUIDELINE;
PREGNANCY DIABETES MELLITUS;
REVIEW;
RISK FACTOR;
SCREENING TEST;
SELF MONITORING;
STREPTOCOCCUS INFECTION;
WEIGHT GAIN;
|
EID: 0347867354
PISSN: 14992671
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (465)
|
References (0)
|